5 completed. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
Follow rHuEPO: new trials by email Literature Review of rHuEPO trials Research Report on rHuEPO
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of R744 to Hemodialysis Patients R744, rHuEPO, R744 placebo - Hemodialysis Patients | Phase 3 | Completed | Chugai Pharmaceutical | 134 | 2007-06-01 | 2009-02-02 |
| Recombinant Human Erythropoietin Compared to Autologous Pre-Donation Prior to Scoliosis Surgery in Children. rHuEpo - Scoliosis | Phase 3 | Completed | University of British Columbia | 20 | 2004-10-01 | 2008-09-25 |
| Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy rHuEPO, Darbepoetin alfa - Cancer, Non-Myeloid Malignancies | Phase 3 | Completed | Amgen | 718 | 2003-02-01 | 2008-02-28 |
| Anemia in Patients With a Non-Myeloid Malignancy Darbepoetin alfa, rHuEPO - Neoplasms, Anemia | Phase 3 | Completed | Amgen | 707 | 2002-01-01 | 2008-09-15 |
| NESP Pediatric Study darbepoetin alfa, rHuEPO - Pre-dialysis, End Stage Renal Disease | Phase 3 | Completed | Amgen | 120 | 2000-08-01 | 2013-05-08 |
Anemia (2) · Neoplasms (2) · Hemorrhage (1) · Kidney Failure, Chronic (1) · Scoliosis (1)
Amgen (3) · Chugai Pharmaceutical (1) · University of British Columbia (1)
Canada (1) · Japan (1)
Eleanor Reimer, MD (1) · Takanori Baba (1)